Clearmind Medicine Inc (CMND)

$1.64

-0.07

(-4.09%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $1.58
    $1.73
    $1.64
    downward going graph

    3.66%

    Downside

    Day's Volatility :8.41%

    Upside

    4.93%

    downward going graph
  • $0.92
    $16.19
    $1.64
    downward going graph

    43.87%

    Downside

    52 Weeks Volatility :94.31%

    Upside

    89.87%

    downward going graph

Returns

PeriodClearmind Medicine IncIndex (Russel 2000)
3 Months
37.82%
0.0%
6 Months
62.38%
0.0%
1 Year
-86.98%
0.0%
3 Years
-99.07%
-19.4%

Highlights

Market Capitalization
5.4M
Book Value
$1.4
Earnings Per Share (EPS)
7.87
PE Ratio
0.21
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-46.34%
Return On Equity TTM
-173.29%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-5.5M
Diluted Eps TTM
7.87
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Clearmind Medicine Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Clearmind Medicine Inc
Clearmind Medicine Inc
28.12%
62.38%
-86.98%
-99.07%
-99.07%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Clearmind Medicine Inc
Clearmind Medicine Inc
0.21
0.21
NA
0.0
-1.73
-0.46
NA
1.4
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Clearmind Medicine Inc
Clearmind Medicine Inc
NA
$5.4M
-99.07%
0.21
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Clearmind Medicine Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 59.9% return, outperforming this stock by 146.9%

Institutional Holdings

  • AdvisorShares Investments, LLC

    3.46%
  • Susquehanna International Group, LLP

    0.74%
  • Geode Capital Management, LLC

    0.50%
  • Royal Bank of Canada

    0.02%

Company Information

Organization
Clearmind Medicine Inc
Employees
0
CEO
Dr. Adi Zuloff-Shani Ph.D.
Industry
Financial Conglomerates

FAQs